Satellos Bioscience Inc (MSCL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 3 | 0 | 1 | 8 | 2 |
| Accounts receivable | -18 | 151 | 98 | -320 | 598 |
| Other Working Capital | 803 | 319 | -1,865 | -687 | 255 |
| Other Operating Activity | -4,914 | -5,313 | -5,600 | -3,697 | -4,223 |
| Operating Cash Flow | $-4,126 | $-4,843 | $-7,366 | $-4,696 | $-3,368 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3 | -3 | 0 | 0 | 0 |
| Purchase Of Investment | -15,329 | 0 | 0 | N/A | N/A |
| Sale Of Investment | 0 | 8,475 | 0 | 17,139 | 13,107 |
| Other Investing Activity | 0 | 0 | 0 | -26,015 | 0 |
| Investing Cash Flow | $-15,332 | $8,472 | $0 | $-8,875 | $13,107 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 29,823 | 0 |
| Other Financing Activity | 700 | 1,392 | 2 | 7,268 | 164 |
| Financing Cash Flow | $700 | $1,392 | $2 | $37,091 | $164 |
| Exchange Rate Effect | -155 | 484 | 3 | 276 | 35 |
| Beginning Cash Position | 38,217 | 32,712 | 40,073 | 17,336 | 7,177 |
| End Cash Position | 19,304 | 38,217 | 32,712 | 40,175 | 17,336 |
| Net Cash Flow | $-18,758 | $5,021 | $-7,364 | $23,520 | $9,902 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,126 | -4,843 | -7,366 | -4,696 | -3,368 |
| Capital Expenditure | -3 | N/A | N/A | N/A | 0 |
| Free Cash Flow | -4,129 | -4,843 | -7,366 | -4,696 | -3,368 |